Health & Fitness
Health and Fitness
Health and Fitness
Mon, October 10, 2011
Sun, October 9, 2011
Sat, October 8, 2011
Fri, October 7, 2011
Analyst View, Impact of Global Events - Research Report on MELA Sciences, Inc. and SIGA Technologies, Inc.
October 07, 2011 09:00 ET
Analyst View, Impact of Global Events - Research Report on MELA Sciences, Inc. and SIGA Technologies, Inc.
HONG KONG--(Marketwire - Oct 7, 2011) - Today, [ www.WorldStreetFundamentals.com ] released its industry report highlighting MELA Sciences, Inc. (
Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets.'
As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.
Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.
World Street Fundamentals has highlighted MELA Sciences, Inc. for its current position within the healthcare industry. MELA Sciences, Inc., formerly Electro-Optical Sciences, Inc., is a medical device company focused on the design, development and commercialization of a non-invasive, point-of-care (in the doctor's office) instrument to assist in the early diagnosis of melanoma. The entire report on MELA Sciences, Inc. (
World Street has featured SIGA Technologies, Inc. for its development within the healthcare industry. SIGA Technologies, Inc. (SIGA), incorporated on December 28, 1995, is engaged in the research, development and commercialization of products for the prevention and treatment of serious infectious diseases, including products for use in defense against biological warfare agents, such as smallpox and Arenaviruses. The entire report on SIGA Technologies, Inc. (
About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.
